FDA Panel Deluged With Conflicting Paclitaxel-Device Data in PAD - Medscape

FDA Panel Deluged With Conflicting Paclitaxel-Device Data in PAD  Medscape

The US Food and Drug Administration's (FDA's) Circulatory System Devices Panel advisory committee unanimously agreed that there is a late mortality signal in ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more